nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfaphenazole—CYP2B6—malignant glioma	0.919	1	CbGaD
Sulfaphenazole—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00143	0.0187	CbGpPWpGaD
Sulfaphenazole—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00141	0.0186	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Xenobiotics—CYP2C18—malignant glioma	0.00137	0.018	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Oxidation by Cytochrome P450—POR—malignant glioma	0.00127	0.0167	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00121	0.0159	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.00111	0.0146	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Xenobiotics—CYP2C18—malignant glioma	0.0011	0.0145	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00108	0.0142	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.00108	0.0142	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00104	0.0137	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00103	0.0136	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.000987	0.013	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.000934	0.0123	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.000885	0.0116	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.000877	0.0115	CbGpPWpGaD
Sulfaphenazole—Sulfasalazine—PPARG—malignant glioma	0.000867	0.195	CrCbGaD
Sulfaphenazole—Dapsone—CYP2C18—malignant glioma	0.00085	0.191	CrCbGaD
Sulfaphenazole—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.000767	0.0101	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00076	0.00999	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000655	0.0086	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000646	0.00849	CbGpPWpGaD
Sulfaphenazole—Sulfasalazine—PTGS1—malignant glioma	0.00064	0.144	CrCbGaD
Sulfaphenazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000602	0.00791	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000574	0.00753	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000568	0.00746	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00056	0.00736	CbGpPWpGaD
Sulfaphenazole—Celecoxib—PTGS2—malignant glioma	0.00054	0.122	CrCbGaD
Sulfaphenazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000531	0.00697	CbGpPWpGaD
Sulfaphenazole—Sulfamethoxazole—PTGS1—malignant glioma	0.00053	0.119	CrCbGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—FTH1—malignant glioma	0.000485	0.00638	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—malignant glioma	0.000475	0.00624	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00046	0.00605	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000458	0.00602	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000452	0.00594	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000447	0.00588	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000442	0.0058	CbGpPWpGaD
Sulfaphenazole—Dapsone—PTGS1—malignant glioma	0.000415	0.0933	CrCbGaD
Sulfaphenazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000388	0.00509	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000383	0.00503	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000374	0.00491	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000371	0.00488	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000367	0.00482	CbGpPWpGaD
Sulfaphenazole—Sulfasalazine—PTGS2—malignant glioma	0.000366	0.0823	CrCbGaD
Sulfaphenazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000364	0.00478	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000363	0.00476	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000363	0.00476	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000359	0.00472	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000349	0.00458	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00034	0.00447	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000318	0.00418	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000316	0.00415	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000314	0.00413	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000314	0.00413	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000312	0.00409	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000298	0.00391	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000295	0.00388	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—CYP2B6—malignant glioma	0.000282	0.0037	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000282	0.0037	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000277	0.00364	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000266	0.0035	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000258	0.00339	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000256	0.00336	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—CYP2C18—malignant glioma	0.000245	0.00321	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000238	0.00313	CbGpPWpGaD
Sulfaphenazole—Dapsone—PTGS2—malignant glioma	0.000237	0.0534	CrCbGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTT1—malignant glioma	0.000198	0.0026	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—CYP2C18—malignant glioma	0.000197	0.00259	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000196	0.00257	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000195	0.00256	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—SLC5A5—malignant glioma	0.000194	0.00255	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000194	0.00255	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.000193	0.00253	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.00019	0.0025	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—PTGS1—malignant glioma	0.000185	0.00243	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—SLC6A3—malignant glioma	0.000185	0.00243	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000184	0.00241	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.000167	0.00219	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.000165	0.00216	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTT1—malignant glioma	0.00016	0.0021	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—TP53—malignant glioma	0.000158	0.00208	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000158	0.00208	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000157	0.00206	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—GSTP1—malignant glioma	0.000156	0.00205	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000156	0.00205	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000155	0.00203	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—PTGS1—malignant glioma	0.00015	0.00196	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—RTEL1—malignant glioma	0.000139	0.00182	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000137	0.0018	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTP1—malignant glioma	0.000137	0.0018	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000136	0.00179	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000135	0.00178	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.000135	0.00177	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000134	0.00176	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00013	0.00171	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.000127	0.00166	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—PDGFB—malignant glioma	0.000124	0.00162	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—RTEL1—malignant glioma	0.000112	0.00147	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000111	0.00146	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTP1—malignant glioma	0.000111	0.00145	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.00011	0.00144	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTP1—malignant glioma	0.000109	0.00143	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000106	0.00139	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000104	0.00137	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000103	0.00135	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—RTEL1—malignant glioma	9.47e-05	0.00124	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTP1—malignant glioma	9.37e-05	0.00123	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	9.24e-05	0.00121	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—COX8A—malignant glioma	7.96e-05	0.00105	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—RTEL1—malignant glioma	7.77e-05	0.00102	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—RTEL1—malignant glioma	7.71e-05	0.00101	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTP1—malignant glioma	7.69e-05	0.00101	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	7.62e-05	0.001	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	7.58e-05	0.000996	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	7.52e-05	0.000987	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—ASMT—malignant glioma	6.77e-05	0.000889	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.77e-05	0.000889	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.55e-05	0.00086	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—COX8A—malignant glioma	6.42e-05	0.000844	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—BCAN—malignant glioma	6.37e-05	0.000836	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.51e-05	0.000723	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—ASMT—malignant glioma	5.46e-05	0.000717	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—COX8A—malignant glioma	5.44e-05	0.000714	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.33e-05	0.0007	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—BCAN—malignant glioma	5.14e-05	0.000674	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—IDH2—malignant glioma	5.13e-05	0.000674	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.86e-05	0.000638	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CYP2B6—malignant glioma	4.82e-05	0.000633	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—ASMT—malignant glioma	4.62e-05	0.000607	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.52e-05	0.000594	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—COX8A—malignant glioma	4.46e-05	0.000586	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—COX8A—malignant glioma	4.43e-05	0.000581	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—IDH1—malignant glioma	4.41e-05	0.000579	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—BCAN—malignant glioma	4.35e-05	0.000571	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—SPHK1—malignant glioma	4.27e-05	0.000561	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CYP2C18—malignant glioma	4.18e-05	0.000549	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—IDH2—malignant glioma	4.14e-05	0.000544	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.96e-05	0.00052	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—ASMT—malignant glioma	3.8e-05	0.000499	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—ASMT—malignant glioma	3.76e-05	0.000494	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.68e-05	0.000483	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—BCAN—malignant glioma	3.57e-05	0.000469	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—IDH1—malignant glioma	3.56e-05	0.000467	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—BCAN—malignant glioma	3.54e-05	0.000465	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—IDH2—malignant glioma	3.5e-05	0.00046	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—SPHK1—malignant glioma	3.44e-05	0.000452	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTT1—malignant glioma	3.38e-05	0.000444	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CYP2C18—malignant glioma	3.37e-05	0.000443	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.3e-05	0.000434	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CYP2B6—malignant glioma	3.3e-05	0.000433	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTGS1—malignant glioma	3.17e-05	0.000416	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—IDH1—malignant glioma	3.01e-05	0.000396	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—BCHE—malignant glioma	2.95e-05	0.000387	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—SPHK1—malignant glioma	2.92e-05	0.000383	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—SLC5A5—malignant glioma	2.91e-05	0.000382	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—IDH2—malignant glioma	2.88e-05	0.000378	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.86e-05	0.000375	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—IDH2—malignant glioma	2.85e-05	0.000375	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTT1—malignant glioma	2.73e-05	0.000358	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.71e-05	0.000355	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.69e-05	0.000354	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.69e-05	0.000353	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.68e-05	0.000352	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTGS1—malignant glioma	2.56e-05	0.000336	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—IDH1—malignant glioma	2.47e-05	0.000325	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.45e-05	0.000322	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—IDH1—malignant glioma	2.45e-05	0.000322	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—SPHK1—malignant glioma	2.39e-05	0.000314	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—BCHE—malignant glioma	2.38e-05	0.000312	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—SPHK1—malignant glioma	2.37e-05	0.000312	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.37e-05	0.000311	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.35e-05	0.000308	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CYP2C18—malignant glioma	2.35e-05	0.000308	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTP1—malignant glioma	2.34e-05	0.000308	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.33e-05	0.000305	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTT1—malignant glioma	2.31e-05	0.000303	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CAT—malignant glioma	2.28e-05	0.0003	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.19e-05	0.000288	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTGS1—malignant glioma	2.17e-05	0.000284	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.16e-05	0.000283	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NCOR1—malignant glioma	2.15e-05	0.000283	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—BCHE—malignant glioma	2.01e-05	0.000264	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2e-05	0.000262	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.99e-05	0.000261	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.93e-05	0.000253	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTT1—malignant glioma	1.9e-05	0.000249	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTP1—malignant glioma	1.89e-05	0.000248	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTT1—malignant glioma	1.88e-05	0.000247	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.88e-05	0.000247	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.86e-05	0.000245	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CAT—malignant glioma	1.84e-05	0.000242	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTGS1—malignant glioma	1.78e-05	0.000233	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTGS1—malignant glioma	1.76e-05	0.000231	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CAV1—malignant glioma	1.76e-05	0.000231	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.76e-05	0.000231	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NCOR1—malignant glioma	1.74e-05	0.000228	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—BCHE—malignant glioma	1.65e-05	0.000217	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—BCHE—malignant glioma	1.64e-05	0.000215	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.63e-05	0.000214	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.62e-05	0.000213	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.62e-05	0.000213	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTP1—malignant glioma	1.6e-05	0.00021	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.6e-05	0.00021	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CAT—malignant glioma	1.56e-05	0.000205	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PPARG—malignant glioma	1.54e-05	0.000203	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.53e-05	0.000201	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.52e-05	0.000199	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NCOR1—malignant glioma	1.47e-05	0.000193	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CAV1—malignant glioma	1.42e-05	0.000186	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.41e-05	0.000185	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.32e-05	0.000174	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTP1—malignant glioma	1.31e-05	0.000173	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTP1—malignant glioma	1.3e-05	0.000171	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.29e-05	0.00017	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CAT—malignant glioma	1.28e-05	0.000168	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CAT—malignant glioma	1.27e-05	0.000167	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PPARG—malignant glioma	1.25e-05	0.000164	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.23e-05	0.000161	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTGS2—malignant glioma	1.21e-05	0.00016	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NCOR1—malignant glioma	1.21e-05	0.000159	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CAV1—malignant glioma	1.2e-05	0.000158	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NCOR1—malignant glioma	1.2e-05	0.000157	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.15e-05	0.000151	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.13e-05	0.000149	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.09e-05	0.000144	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTEN—malignant glioma	1.06e-05	0.000139	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PPARG—malignant glioma	1.05e-05	0.000139	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PIK3CB—malignant glioma	9.89e-06	0.00013	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CAV1—malignant glioma	9.85e-06	0.000129	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTGS2—malignant glioma	9.8e-06	0.000129	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CAV1—malignant glioma	9.76e-06	0.000128	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PIK3CD—malignant glioma	9.61e-06	0.000126	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.33e-06	0.000123	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.97e-06	0.000118	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	8.89e-06	0.000117	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PPARG—malignant glioma	8.66e-06	0.000114	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PPARG—malignant glioma	8.58e-06	0.000113	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTEN—malignant glioma	8.55e-06	0.000112	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PIK3CB—malignant glioma	8.37e-06	0.00011	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTGS2—malignant glioma	8.3e-06	0.000109	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.89e-06	0.000104	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	7.82e-06	0.000103	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PIK3CA—malignant glioma	7.47e-06	9.81e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTEN—malignant glioma	7.24e-06	9.5e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.87e-06	9.03e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.82e-06	8.95e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTGS2—malignant glioma	6.81e-06	8.95e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTGS2—malignant glioma	6.75e-06	8.87e-05	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—AKT1—malignant glioma	6.1e-06	8.02e-05	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PIK3CA—malignant glioma	6.03e-06	7.92e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTEN—malignant glioma	5.94e-06	7.8e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTEN—malignant glioma	5.89e-06	7.73e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PIK3CA—malignant glioma	5.1e-06	6.7e-05	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—AKT1—malignant glioma	4.93e-06	6.47e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.19e-06	5.5e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—AKT1—malignant glioma	4.17e-06	5.48e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.15e-06	5.46e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—AKT1—malignant glioma	3.42e-06	4.5e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—AKT1—malignant glioma	3.39e-06	4.46e-05	CbGpPWpGaD
